Integral Diagnostics

Integral Diagnostics is a company listed under the stock ticker IDX (AU).

View the org chart displaying its 12 main executives

Most searched biographies at Integral Diagnostics

• Ian Kadish, Director, Managing Director and Chief Executive Officer
• Toby Hall, Chairman of the Board
• Raelene Murphy, Independent Non-Executive Director

Popular executive movements at Integral Diagnostics

• Deborah Ambrosini has joined the company as Interim Company Secretary  (posted on May 6 2024).
• Helen Kurincic, Independent Non-Executive Chairman, will retire on Oct. 29, 2023  (posted on September 29 2023).
• Toby Hall who is Director, will be promoted to Chairman of the Board on Oct. 29, 2023  (posted on September 29 2023).

Create your alert
to follow the executive moves at Integral Diagnostics.

Integral Diagnostics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Integral Diagnostics

• News - IDX Group | Integral Diagnostics | Medical Imaging Services | AUS | NZ

Social media about Integral Diagnostics

• Integral Diagnostics on Wikipedia, Google News & Yahoo Finance
• Integral Diagnostics on LinkedIn, Twitter & YouTube

Contact by email its executives including Ian Kadish

Call Integral Diagnostics at +61 35...

View the org chart

Register to receive your alert

Report an error